financetom
Business
financetom
/
Business
/
Truist's profit falls on hit from securities sale, lower interest income
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Truist's profit falls on hit from securities sale, lower interest income
Jul 22, 2024 4:51 AM

July 22 (Reuters) - Truist Financial ( TFC ) reported a

33% drop in second-quarter profit on Monday, dragged down by a

$5.1 billion loss on the sale of some securities and lower net

interest income (NII).

The bank's results mirror earnings at several lenders, which

have seen a decline in NII as high interest rates impede loan

demand.

NII fell 2% to $3.58 billion. Average loans and leases

decreased 6% from same quarter last year, Truist said.

The bank in May sold a portfolio of low-yielding securities

to focus on better alternatives, leading to an after-tax loss of

$5.1 billion, in a move that it said would help push its 2024

revenue higher than previously forecast.

Its second-quarter profit was also dragged down by a $150

million charitable contribution and restructuring charges of $96

million, partly offset by a gain from the sale of its insurance

business, the bank said.

Net income available to common shareholders fell to $826

million, or 62 cents per share, for the quarter ended June. That

compares with $1.23 billion, or 92 cents per share, in the

year-ago period.

Truist's shares fell nearly 1% in premarket trading.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
IDEXX Laboratories Q4 Earnings, Revenue Rise; 2025 Outlook Issued
IDEXX Laboratories Q4 Earnings, Revenue Rise; 2025 Outlook Issued
Feb 3, 2025
06:40 AM EST, 02/03/2025 (MT Newswires) -- IDEXX Laboratories ( IDXX ) reported Q4 earnings Monday of $2.62 per diluted share, up from $2.32 a year earlier. Analysts polled by FactSet expected $2.40. Revenue for the quarter ended Dec. 31 was $954.3 million, compared with $901.6 million a year earlier. Analysts surveyed by FactSet expected $935.1 million. The company expects...
AstraZeneca Small Cell Lung Cancer Treatment Gets EU Recommendation as Monotherapy
AstraZeneca Small Cell Lung Cancer Treatment Gets EU Recommendation as Monotherapy
Feb 3, 2025
06:42 AM EST, 02/03/2025 (MT Newswires) -- AstraZeneca ( AZN ) said Monday that its drug, Imfinzi, was recommended for approval in the European Union as a monotherapy for limited-stage small cell lung cancer in adults. The company said the recommendation by the European Medicines Agency's Committee for Medicinal Products for Human Use was based on phase 3 trial results,...
Colombia's Ecopetrol and Occidental Petroleum extend contract in Permian basin
Colombia's Ecopetrol and Occidental Petroleum extend contract in Permian basin
Feb 3, 2025
BOGOTA, Feb 3 (Reuters) - Colombia's majority state-owned energy company Ecopetrol has reached an agreement to extend a contract with Occidental Petroleum ( OXY ) in the U.S. Permian basin, it said in a statement on Monday. The plan includes investments of $880 million, the statement said, and eyes drilling some 91 wells in the sub-basins of Midland and Delaware....
Maravai LifeSciences' TriLink BioTechnologies Partners With Avantor to Expand Nucleic Acid Product Availability in EMEA
Maravai LifeSciences' TriLink BioTechnologies Partners With Avantor to Expand Nucleic Acid Product Availability in EMEA
Feb 3, 2025
06:41 AM EST, 02/03/2025 (MT Newswires) -- Maravai LifeSciences' ( MRVI ) TriLink BioTechnologies said Monday it partnered with Avantor ( AVTR ) to expand the availability of its innovative nucleic acid products to customers across Europe, the Middle East, and Africa. The company said the distribution partnership is expected to streamline the ordering process and shorten lead times for...
Copyright 2023-2026 - www.financetom.com All Rights Reserved